131 related articles for article (PubMed ID: 11676289)
1. The effects of AbetaPP mutations and APOE polymorphisms on cerebral amyloid angiopathy.
Rebeck GW; Cho HS; Grabowski TJ; Greenberg SM
Amyloid; 2001 Jul; 8 Suppl 1():43-7. PubMed ID: 11676289
[TBL] [Abstract][Full Text] [Related]
2. A novel AbetaPP mutation exclusively associated with cerebral amyloid angiopathy.
Obici L; Demarchi A; de Rosa G; Bellotti V; Marciano S; Donadei S; Arbustini E; Palladini G; Diegoli M; Genovese E; Ferrari G; Coverlizza S; Merlini G
Ann Neurol; 2005 Oct; 58(4):639-44. PubMed ID: 16178030
[TBL] [Abstract][Full Text] [Related]
3. Abeta species, including IsoAsp23 Abeta, in Iowa-type familial cerebral amyloid angiopathy.
Shin Y; Cho HS; Fukumoto H; Shimizu T; Shirasawa T; Greenberg SM; Rebeck GW
Acta Neuropathol; 2003 Mar; 105(3):252-8. PubMed ID: 12557012
[TBL] [Abstract][Full Text] [Related]
4. Cerebral amyloid angiopathy and dementia.
Tian J; Shi J; Mann DM
Panminerva Med; 2004 Dec; 46(4):253-64. PubMed ID: 15876981
[TBL] [Abstract][Full Text] [Related]
5. [Genetic factors for cerebral amyloid angiopathy].
Hamaguchi T; Yamada M
Brain Nerve; 2008 Nov; 60(11):1275-83. PubMed ID: 19069161
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model.
Holtzman DM; Fagan AM; Mackey B; Tenkova T; Sartorius L; Paul SM; Bales K; Ashe KH; Irizarry MC; Hyman BT
Ann Neurol; 2000 Jun; 47(6):739-47. PubMed ID: 10852539
[TBL] [Abstract][Full Text] [Related]
7. [Biological characteristics of amyloid precursor protein and Alzheimer's disease].
Fukatsu R; Tsuzuki K; Takamaru Y; Hayashi Y; Sasaki N; Yoshida T; Midorikawa Y; Fujii N; Takahata N
Rinsho Byori; 1996 Mar; 44(3):213-24. PubMed ID: 8857163
[TBL] [Abstract][Full Text] [Related]
8. Cerebrovascular smooth muscle cells internalize Alzheimer amyloid beta protein via a lipoprotein pathway: implications for cerebral amyloid angiopathy.
Urmoneit B; Prikulis I; Wihl G; D'Urso D; Frank R; Heeren J; Beisiegel U; Prior R
Lab Invest; 1997 Aug; 77(2):157-66. PubMed ID: 9274858
[TBL] [Abstract][Full Text] [Related]
9. Occurrence and co-localization of amyloid beta-protein and apolipoprotein E in perivascular drainage channels of wild-type and APP-transgenic mice.
Thal DR; Larionov S; Abramowski D; Wiederhold KH; Van Dooren T; Yamaguchi H; Haass C; Van Leuven F; Staufenbiel M; Capetillo-Zarate E
Neurobiol Aging; 2007 Aug; 28(8):1221-30. PubMed ID: 16815595
[TBL] [Abstract][Full Text] [Related]
10. Co-expression of beta-amyloid precursor protein (betaAPP) and apolipoprotein E in cell culture: analysis of betaAPP processing.
Biere AL; Ostaszewski B; Zhao H; Gillespie S; Younkin SG; Selkoe DJ
Neurobiol Dis; 1995 Jun; 2(3):177-87. PubMed ID: 9174001
[TBL] [Abstract][Full Text] [Related]
11. A nontransgenic mouse model shows inducible amyloid-beta (Abeta) peptide deposition and elucidates the role of apolipoprotein E in the amyloid cascade.
Dolev I; Michaelson DM
Proc Natl Acad Sci U S A; 2004 Sep; 101(38):13909-14. PubMed ID: 15365176
[TBL] [Abstract][Full Text] [Related]
12. Cerebral amyloid angiopathy and gene polymorphisms.
Yamada M
J Neurol Sci; 2004 Nov; 226(1-2):41-4. PubMed ID: 15537517
[TBL] [Abstract][Full Text] [Related]
13. Alpha7 nicotinic acetylcholine receptor expression by vascular smooth muscle cells facilitates the deposition of Abeta peptides and promotes cerebrovascular amyloid angiopathy.
Clifford PM; Siu G; Kosciuk M; Levin EC; Venkataraman V; D'Andrea MR; Nagele RG
Brain Res; 2008 Oct; 1234():158-71. PubMed ID: 18708033
[TBL] [Abstract][Full Text] [Related]
14. Cerebral beta-amyloid deposition is augmented by the -491AA promoter polymorphism in non-demented elderly individuals bearing the apolipoprotein E epsilon4 allele.
Pahnke J; Walker LC; Schroeder E; Vogelgesang S; Stausske D; Walther R; Warzok RW
Acta Neuropathol; 2003 Jan; 105(1):25-9. PubMed ID: 12471457
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E co-localizes with newly formed amyloid beta-protein (Abeta) deposits lacking immunoreactivity against N-terminal epitopes of Abeta in a genotype-dependent manner.
Thal DR; Capetillo-Zarate E; Schultz C; Rüb U; Saido TC; Yamaguchi H; Haass C; Griffin WS; Del Tredici K; Braak H; Ghebremedhin E
Acta Neuropathol; 2005 Nov; 110(5):459-71. PubMed ID: 16195918
[TBL] [Abstract][Full Text] [Related]
16. Interaction with amyloid beta peptide compromises the lipid binding function of apolipoprotein E.
Tamamizu-Kato S; Cohen JK; Drake CB; Kosaraju MG; Drury J; Narayanaswami V
Biochemistry; 2008 May; 47(18):5225-34. PubMed ID: 18407659
[TBL] [Abstract][Full Text] [Related]
17. Cerebral amyloid angiopathy in a 95+ cohort: complement activation and apolipoprotein E (ApoE) genotype.
Tanskanen M; Lindsberg PJ; Tienari PJ; Polvikoski T; Sulkava R; Verkkoniemi A; Rastas S; Paetau A; Kiuru-Enari S
Neuropathol Appl Neurobiol; 2005 Dec; 31(6):589-99. PubMed ID: 16281907
[TBL] [Abstract][Full Text] [Related]
18. [Advances in molecular biology and clinical study of amyloid precursor protein for Alzheimer's disease].
Xu BG; Wu X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):201-9. PubMed ID: 15171563
[TBL] [Abstract][Full Text] [Related]
19. Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits.
Yao J; Petanceska SS; Montine TJ; Holtzman DM; Schmidt SD; Parker CA; Callahan MJ; Lipinski WJ; Bisgaier CL; Turner BA; Nixon RA; Martins RN; Ouimet C; Smith JD; Davies P; Laska E; Ehrlich ME; Walker LC; Mathews PM; Gandy S
J Neurochem; 2004 Aug; 90(4):1011-8. PubMed ID: 15287908
[TBL] [Abstract][Full Text] [Related]
20. Cerebral amyloid angiopathy: pathogenetic mechanisms and link to dense amyloid plaques.
Kumar-Singh S
Genes Brain Behav; 2008 Feb; 7 Suppl 1():67-82. PubMed ID: 18184371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
